Home > Stock channel >                 text

Southern Pharmaceutical intends to raise no more than 70 million yuan

May 15, 2019 01:44
source: Rhinoceros star

Oriental Fortune APP

  • Convenient
  • Mobile phone viewing financial news
  • Professional, rich
  • Master the pulse of the market

Read articles on your phone

  • prompt:
  • WeChat sweep
  • Share it with you
  • Circle of friends
Summary
[Southern Pharmaceuticals plans to raise no more than 70 million yuan] On May 14, Nanfang Pharmaceutical (831207) announced that the company plans to issue no more than 20 million shares at a price of 3.50 yuan per share, raising no more than 70 million yuan. (Rhinoceros star)

K map 831207_60

On May 14, Nanfang Pharmaceutical (831207) releasedannouncementThe company plans to issue no more than 20 million shares at a price of 3.50 yuan per share, raising no more than 70 million yuan.

Southern Pharmaceuticals said that the fundraising will be used to supplement working capital; two new production lines and supporting facilities that meet European and American certification standards will be built; and the area for raw material cultivation will be expanded.

Nanfang Pharmaceutical's main business is the development, production and sales of taxanes and other anti-tumor APIs and pharmaceutical intermediates.

(Article source: Rhinoceros Star)

                (Editor: DF512)

you might be interested
  • News
  • stock
  • global
  • Hong Kong stocks
  • US stocks
  • futures
  • Foreign exchange
  • life
    click to see more
    No more recommendations
    • name
    • Latest price
    • Quote change
    • Hand turnover rate
    • Capital inflow
    Please download Oriental Fortune products to view real-time quotes and more data.
    Click ranking
    Solemnly declare:Oriental Fortune.com publishes this information in order to disseminate more information and has nothing to do with the position of this website. Oriental Fortune Network does not guarantee the accuracy, authenticity, completeness, validity, timeliness, originality, etc. of all or part of this information (including but not limited to text, data and graphics). The relevant information has not been confirmed by this website, and does not constitute any investment advice for you. According to this operation, the risk is at your own risk.